{
    "nctId": "NCT01569321",
    "briefTitle": "Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study",
    "officialTitle": "Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "N/A",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "MEASURE the Positron Emission Mammography (PEM)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\> 18 years\n* Mammary N\u00e9oplasia ready(in position) (diagnosed on histological taking of type(chap) biopsy)\n* Waits whose realization of an imaging TEP-TDM in the 18FDG is required for the coverage(care) of a mammary n\u00e9oplasia. The decision of realization of this TEP-TDM can be validated during a RCP.\n\nExclusion Criteria:\n\n* Other cancerous affection;\n* Pregnant Woman. Nursing mother\n* Patient presenting difficulties of follow-up (insufficient motivation, imminent transfer(transformation) in a city where the study cannot be led)\n* Patient incapable to give their written consent.\n* Patient claustrophobic or presenting a contraindication to the realization of the MRI",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}